Drug Pipeline

Fingolimod Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
2
Recruiting
6
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
5
Phase 2/3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04480853 Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing… Multiple Sclerosis Recruiting
Phase 3
NCT06408259 Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in… Multiple Sclerosis, Relapsing-Remitting Recruiting
NCT05123703 A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in… Relapsing-Remitting Multiple Sclerosis Active, Not Recruiting
NCT07483632 A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF)… Relapsing Forms of Multiple Sclerosis Not Yet Recruiting
NCT04926818 Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric… Multiple Sclerosis (MS) Active, Not Recruiting
NCT01892722 Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis Multiple Sclerosis Active, Not Recruiting
Phase 2/3
NCT07220252 Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of… Relapsing Multiple Sclerosis Not Yet Recruiting
Not specified
NCT05688436 A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants… Multiple Sclerosis Active, Not Recruiting
Sponsors Running Fingolimod Trials
Disease Areas
Get alerts when Fingolimod trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free